Geisel School of Medicine at Dartmouth

Contact Info:

Amber Barrows

One Medical Center Drive

Lebanon, NH 03756

https://cancer.dartmouth.edu/scientists-researchers/pathology-shared-resource

Grants and Identifiers:

RRID: RRID:SCR_023479

Instrumentation:

Services Provided:

Assay Development

Clinical Trial Support

Immunohistochemistry

Staining

Tissue Embed

Tissue MicroArray

Whole Slide Imaging

Relevant Publications:

1.) Tau S, Chamberlin MD, Yang H, Marotti JD, Roberts AM, Carmichael MM, Cressey L, Dragnev C, Demidenko E, Hampsch RA, Soucy SM, Kolling F, Samkoe KS, Alvarez JV, Kettenbach AN, Miller TW (2024 Sep 27). Endocrine persistence in ER+ breast cancer is accompanied by metabolic vulnerability in oxidative phosphorylation. bioRxiv : the preprint server for biology, (), . . PMID: 39386444.

2.) Jones VM, Thompson LDR, Pettus JR, Green DC, Lefferts JA, Shah PS, Tsongalis GJ, Sajed DP, Guilmette JM, Lewis JS, Fisch AS, Tafe LJ, Kerr DA (2024 Sep 8). Angiomyolipomatous Lesions of the Nasal Cavity (Sinonasal Angioleiomyoma with Adipocytic Differentiation): A Multi-Institutional Immunohistochemical and Molecular Study. Research square, (), . . PMID: 39281855.

3.) Bentz JL, Barney RE, Georgantzoglou N, Manxhuka-Kerliu S, Ibishi VA, Dacaj-Elshani B, Bejarano S, Palumbo PE, Suresh A, LaRochelle EPM, Keegan WP, Wilson TL, Dokus BJ, Hershberger KC, Gallagher TL, Allen SF, Palisoul SM, Steinmetz HB, Kennedy LS, Tsongalis GJ (2024 Aug 19). High-Risk HPV Screening Initiative in Kosovo-A Way to Optimize HPV Vaccination for Cervical Cancer. Diseases (Basel, Switzerland), 12(8), . . PMID: 39195188.

4.) Bagheri M, Lee MK, Muller KE, Miller TW, Pattabiraman DR, Christensen BC (2024 Mar). Alteration of DNA methyltransferases by eribulin elicits broad DNA methylation changes with potential therapeutic implications for triple-negative breast cancer. Epigenomics, 16(5), 293-308. . PMID: 38356412.

5.) Traphagen NA, Schwartz GN, Tau S, Roberts AM, Jiang A, Hosford SR, Marotti JD, Goen AE, Romo BA, Johnson AL, Duffy EK, Demidenko E, Heverly P, Mosesson Y, Soucy SM, Kolling F, Miller TW (2023 Sep 15). Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 29(18), 3717-3728. . PMID: 37439680.

6.) Schwartz GN, Kaufman PA, Giridhar KV, Marotti JD, Chamberlin MD, Arrick BA, Makari-Judson G, Goetz MP, Soucy SM, Kolling F, Demidenko E, Miller TW (2023 Aug 1). Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 29(15), 2767-2773. . PMID: 37260292.

Description:

Dartmouth-Hitchcock Medical Center / Geisel School of Medicine